PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+6.69%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$11.4B
AUM Growth
+$11.4B
(+5.7%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
322
New
56
Increased
79
Reduced
105
Closed
40
Top Buys
| 1 |
Qualcomm
QCOM
|
$133M |
| 2 |
Uber
UBER
|
$80.1M |
| 3 |
Labcorp
LH
|
$66.1M |
| 4 |
Baxter International
BAX
|
$57.5M |
| 5 |
Analog Devices
ADI
|
$53M |
Top Sells
| 1 |
Abbott
ABT
|
$65.8M |
| 2 |
AABA
Altaba Inc. Common Stock
AABA
|
$57.7M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$54.4M |
| 4 |
Agilent Technologies
A
|
$50M |
| 5 |
HCA Healthcare
HCA
|
$49.7M |
Sector Composition
| 1 | Technology | 29.69% |
| 2 | Financials | 22.5% |
| 3 | Healthcare | 18.14% |
| 4 | Communication Services | 8.23% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Ascendis Pharma
ASND
$11.8B
| $2.88M | 0.03% |
+25,000
| New | +$2.88M |
|
227
KVH Industries
KVHI
$110M
| $2.76M | 0.02% |
253,695
| – | – |
|
|
ARQL
228
DELISTED
Arqule Inc
ARQL
| $2.75M | 0.02% |
+250,000
| New | +$2.75M |
|
|
MRTX
229
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.58M | 0.02% |
+25,000
| New | +$2.58M |
|
230
Replimune Group
REPL
$422M
| $2.57M | 0.02% |
175,000
| – | – |
|
231
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.5M | 0.02% |
+100,000
| New | +$2.5M |
|
232
Supernus Pharmaceuticals
SUPN
$2.53B
| $2.48M | 0.02% |
75,000
| – | – |
|
233
Verisk Analytics
VRSK
$37.5B
| $2.22M | 0.02% |
+15,124
| New | +$2.22M |
|
234
HDFC Bank
HDB
$182B
| $2.17M | 0.02% |
16,679
-1,500
| -8% | -$195K |
|
|
ORTX
235
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.1M | 0.02% |
+150,000
| New | +$2.1M |
|
236
eGain
EGAN
$172M
| $2.02M | 0.02% |
248,428
-76,300
| -23% | -$621K |
|
237
Q32 Bio
QTTB
$20.9M
| $1.96M | 0.02% |
100,000
| – | – |
|
|
BCYC
238
Bicycle Therapeutics
BCYC
$511M
| $1.31M | 0.01% |
+130,000
| New | +$1.31M |
|
239
Kezar Life Sciences
KZR
$28.9M
| $1.16M | 0.01% |
150,000
+50,000
| +50% | +$386K |
|
240
NetEase
NTES
$86.2B
| $935K | 0.01% |
3,655
+607
| +20% | +$155K |
|
|
JOBS
241
DELISTED
51job, Inc.
JOBS
| $893K | 0.01% |
11,829
+2,979
| +34% | +$225K |
|
|
IMMP
242
Immutep
IMMP
$234M
| $835K | 0.01% |
459,260
-40,740
| -8% | -$74.1K |
|
|
VNET
243
VNET Group
VNET
$2.33B
| $732K | 0.01% |
93,936
-21,738
| -19% | -$169K |
|
244
Helius Medical Technologies
HSDT
$6.59M
| $550K | ﹤0.01% |
250,000
-230,826
| -48% | -$508K |
|
|
VRNA
245
Verona Pharma
VRNA
$9.16B
| $510K | ﹤0.01% |
100,000
| – | – |
|
246
Summit Therapeutics
SMMT
$17.6B
| $436K | ﹤0.01% |
344,681
-5,319
| -2% | -$6.73K |
|
247
Mercado Libre
MELI
$125B
| $403K | ﹤0.01% |
+658
| New | +$403K |
|
|
RLM
248
DELISTED
Realm Therapeutics plc American Depositary Shares
RLM
| $351K | ﹤0.01% |
+124,900
| New | +$351K |
|
|
NBIS
249
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| $340K | ﹤0.01% |
8,953
-5,063
| -36% | -$192K |
|
250
Esquire Financial Holdings
ESQ
$838M
| $322K | ﹤0.01% |
12,789
-4,849
| -27% | -$122K |
|